Physician profile
David J Bonda
NPI 1235525163
$2,217.03
in general payments reported to CMS, 2019-2025
8 companies · $34.15 in 2025
The $34.15 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $315 · 2023: $90.45 · 2024: $1,548 · 2025: $34.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013 · Travel and Lodging: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,013.27 |
| Travel and Lodging | $659.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $1,036.82 | 2023-2024 | |
| Livanova USA, INC. | $581.01 | 2024 | Vns Therapy |
| Medtronic, INC. | $260.08 | 2021-2022 | |
| Sanara Medtech INC. | $125.00 | 2022 | |
| Depuy Synthes Sales INC. | $112.14 | 2022 | |
| Penumbra, INC. | $47.08 | 2021 | |
| Stryker Corporation | $34.15 | 2025 | Core, Sonopet Iq |
| Kls-Martin L.P. | $20.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bonda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.